Office of Medical Cannabis Seeks Comment on Proposed New Qualifying Conditions

September 1, 2022

The Office of Medical Cannabis is accepting public written comment on petitions to add qualifying medical conditions for Minnesota’s Medical Cannabis Program. The deadline is the end of business on October 5.  

The petitions under consideration are gastroparesis, irritable bowel syndrome, obsessive compulsive disorder and opioid use disorder.  

The Minnesota Department of Health (MDH) accepts petitions from the public every year from June 1 through July 31 to add a qualifying medical condition or delivery method. No petitions for adding new delivery methods were accepted for consideration. 

You can submit comments via email or by US mail: Office of Medical Cannabis, PO Box 64882, St. Paul, MN 55164.  

This fall, MDH will send all eligible petitions, scientific reviews developed by MDH staff, and public written comments to the Medical Cannabis Review Panel, which will meet to review the materials. The date for the review panel meeting is to be determined. 

By November 1, the panel will provide the health commissioner with a written report of the findings, identifying potential public health benefits and potential risks by adding or not adding a proposed condition. The commissioner will approve or deny petitions by December 1. 

To learn more, visit Petitions Process for Adding Qualifying Medical Conditions, Delivery Methods

Latest News

Legislative Session Starts; MMA to Focus on 5 Major Issues

February 19, 2026

State lawmakers returned to St. Paul on February 17 for the second half of the 2025-2026 biennium. 

MMA Leaders Testify on Medicaid Cuts

February 19, 2026

On the second day of the legislative session, MMA leadership was already advocating for one of its top priorities - minimizing the harm of federal changes to Medical Assistance (MA). 

MMA Priority Bill on AI and Prior Auth Already Moving at the Capitol

February 19, 2026

Legislation to prohibit the use of artificial intelligence (AI) in prior authorization requirements was heard in the House Commerce Finance and Policy Committee on February 19.